schliessen

Filtern

 

Bibliotheken

Male circumcision for prevention of oncogenic HPV infection/Author's reply

The quadrivalent HPV vaccine only reduces external genital lesions in men by 60.2% and persistent infection with any HPV genotype by 27.1%.6 Therefore, several interventions might be required to significantly reduce high-risk HPV infection in men and women, and the potential, albeit incomplete, prot... Full description

Journal Title: The Lancet (British edition) 2011-07-23, Vol.378 (9788), p.314
Main Author: Aaron A R Tobian
Other Authors: Thomas C Quinn , Ronald H Gray , Joseph Monsonego
Format: Electronic Article Electronic Article
Language: English
Subjects:
Men
Quelle: Alma/SFX Local Collection
Publisher: London: Elsevier Limited
ID: ISSN: 0140-6736
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_proquest_journals_879336711
title: Male circumcision for prevention of oncogenic HPV infection/Author's reply
format: Article
creator:
  • Aaron A R Tobian
  • Thomas C Quinn
  • Ronald H Gray
  • Joseph Monsonego
subjects:
  • Cervical cancer
  • Circumcision
  • Human papillomavirus
  • Men
  • Studies
  • Womens health
ispartof: The Lancet (British edition), 2011-07-23, Vol.378 (9788), p.314
description: The quadrivalent HPV vaccine only reduces external genital lesions in men by 60.2% and persistent infection with any HPV genotype by 27.1%.6 Therefore, several interventions might be required to significantly reduce high-risk HPV infection in men and women, and the potential, albeit incomplete, protection afforded by male circumcision cannot be ignored. [...] male circumcision was effective in reducing HPV incidence in female partners, with the best results seen in younger women who had fewer sexual partners.
language: eng
source: Alma/SFX Local Collection
identifier: ISSN: 0140-6736
fulltext: fulltext
issn:
  • 0140-6736
  • 1474-547X
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.3629968
LOCALfalse
PrimoNMBib
record
control
sourceidproquest
recordidTN_cdi_proquest_journals_879336711
sourceformatXML
sourcesystemPC
sourcerecordid2408261991
originalsourceidFETCH-proquest_journals_8793367113
addsrcrecordideNqNiksKwjAUAIMoWD93CG5cFROSJroUUYoguBBxV0p41ZSaV5NG8PYqeABXwzDTIwmXWqaZ1Jc-SRiXLFVaqCEZhVAzxqRiWUL2h7IBaqw38W5ssOhohZ62Hp7guq9iRdEZvIKzhubHM7WuAvNNi3XsbujngXpom9eEDKqyCTD9cUxmu-1pk6etx0eE0BU1Ru8-qVjqlRBKcy7-mt55fD3g
sourcetypeAggregation Database
isCDItrue
recordtypearticle
pqid879336711
display
typearticle
titleMale circumcision for prevention of oncogenic HPV infection/Author's reply
sourceAlma/SFX Local Collection
creatorAaron A R Tobian ; Thomas C Quinn ; Ronald H Gray ; Joseph Monsonego
creatorcontribAaron A R Tobian ; Thomas C Quinn ; Ronald H Gray ; Joseph Monsonego
descriptionThe quadrivalent HPV vaccine only reduces external genital lesions in men by 60.2% and persistent infection with any HPV genotype by 27.1%.6 Therefore, several interventions might be required to significantly reduce high-risk HPV infection in men and women, and the potential, albeit incomplete, protection afforded by male circumcision cannot be ignored. [...] male circumcision was effective in reducing HPV incidence in female partners, with the best results seen in younger women who had fewer sexual partners.
identifier
0ISSN: 0140-6736
1EISSN: 1474-547X
2CODEN: LANCAO
languageeng
publisherLondon: Elsevier Limited
subjectCervical cancer ; Circumcision ; Human papillomavirus ; Men ; Studies ; Womens health
ispartofThe Lancet (British edition), 2011-07-23, Vol.378 (9788), p.314
rightsCopyright Elsevier Limited Jul 23-Jul 29, 2011
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Usyndetics_thumb_exl
search
creatorcontrib
0Aaron A R Tobian
1Thomas C Quinn
2Ronald H Gray
3Joseph Monsonego
title
0Male circumcision for prevention of oncogenic HPV infection/Author's reply
1The Lancet (British edition)
descriptionThe quadrivalent HPV vaccine only reduces external genital lesions in men by 60.2% and persistent infection with any HPV genotype by 27.1%.6 Therefore, several interventions might be required to significantly reduce high-risk HPV infection in men and women, and the potential, albeit incomplete, protection afforded by male circumcision cannot be ignored. [...] male circumcision was effective in reducing HPV incidence in female partners, with the best results seen in younger women who had fewer sexual partners.
subject
0Cervical cancer
1Circumcision
2Human papillomavirus
3Men
4Studies
5Womens health
issn
00140-6736
11474-547X
fulltexttrue
rsrctypearticle
creationdate2011
recordtypearticle
recordideNqNiksKwjAUAIMoWD93CG5cFROSJroUUYoguBBxV0p41ZSaV5NG8PYqeABXwzDTIwmXWqaZ1Jc-SRiXLFVaqCEZhVAzxqRiWUL2h7IBaqw38W5ssOhohZ62Hp7guq9iRdEZvIKzhubHM7WuAvNNi3XsbujngXpom9eEDKqyCTD9cUxmu-1pk6etx0eE0BU1Ru8-qVjqlRBKcy7-mt55fD3g
startdate20110723
enddate20110723
creator
0Aaron A R Tobian
1Thomas C Quinn
2Ronald H Gray
3Joseph Monsonego
generalElsevier Limited
scope
00TT
10TZ
20U~
33V.
47QL
57QP
67RV
77TK
87U7
97U9
107X7
117XB
1288A
1388C
1488E
1588G
1688I
178AF
188AO
198C1
208C2
218FE
228FH
238FI
248FJ
258FK
268G5
27ABUWG
28AN0
29ASE
30AZQEC
31BBNVY
32BEC
33BENPR
34BHPHI
35C1K
36DWQXO
37FPQ
38FYUFA
39GHDGH
40GNUQQ
41GUQSH
42H94
43HCIFZ
44K6X
45K9-
46K9.
47KB0
48KB~
49LK8
50M0R
51M0S
52M0T
53M1P
54M2M
55M2O
56M2P
57M7N
58M7P
59MBDVC
60NAPCQ
61PQEST
62PQQKQ
63PQUKI
64Q9U
65S0X
sort
creationdate20110723
titleMale circumcision for prevention of oncogenic HPV infection/Author's reply
authorAaron A R Tobian ; Thomas C Quinn ; Ronald H Gray ; Joseph Monsonego
facets
frbrtype5
frbrgroupidcdi_FETCH-proquest_journals_8793367113
rsrctypearticles
prefilterarticles
languageeng
creationdate2011
topic
0Cervical cancer
1Circumcision
2Human papillomavirus
3Men
4Studies
5Womens health
toplevel
0peer_reviewed
1online_resources
creatorcontrib
0Aaron A R Tobian
1Thomas C Quinn
2Ronald H Gray
3Joseph Monsonego
collection
0News PRO
1Pharma and Biotech Premium PRO
2Global News & ABI/Inform Professional
3ProQuest Central (Corporate)
4Bacteriology Abstracts (Microbiology B)
5Calcium & Calcified Tissue Abstracts
6Nursing & Allied Health Database
7Neurosciences Abstracts
8Toxicology Abstracts
9Virology and AIDS Abstracts
10Health & Medical Collection
11ProQuest Central (purchase pre-March 2016)
12Biology Database (Alumni Edition)
13Healthcare Administration Database (Alumni)
14Medical Database (Alumni Edition)
15Psychology Database (Alumni)
16Science Database (Alumni Edition)
17STEM Database
18ProQuest Pharma Collection
19Public Health Database
20Lancet Titles
21ProQuest SciTech Collection
22ProQuest Natural Science Collection
23Hospital Premium Collection
24Hospital Premium Collection (Alumni Edition)
25ProQuest Central (Alumni) (purchase pre-March 2016)
26Research Library (Alumni Edition)
27ProQuest Central (Alumni Edition)
28British Nursing Database
29British Nursing Index
30ProQuest Central Essentials
31Biological Science Collection
32eLibrary
33ProQuest Central
34Natural Science Collection
35Environmental Sciences and Pollution Management
36ProQuest Central Korea
37British Nursing Index (BNI) (1985 to Present)
38Health Research Premium Collection
39Health Research Premium Collection (Alumni)
40ProQuest Central Student
41Research Library Prep
42AIDS and Cancer Research Abstracts
43SciTech Premium Collection
44British Nursing Index
45Consumer Health Database (Alumni Edition)
46ProQuest Health & Medical Complete (Alumni)
47Nursing & Allied Health Database (Alumni Edition)
48ProQuest Newsstand Professional
49ProQuest Biological Science Collection
50Consumer Health Database
51Health & Medical Collection (Alumni Edition)
52Healthcare Administration Database
53Medical Database
54Psychology Database
55Research Library
56Science Database
57Algology Mycology and Protozoology Abstracts (Microbiology C)
58Biological Science Database
59Research Library (Corporate)
60Nursing & Allied Health Premium
61ProQuest One Academic Eastern Edition
62ProQuest One Academic
63ProQuest One Academic UKI Edition
64ProQuest Central Basic
65SIRS Editorial
jtitleThe Lancet (British edition)
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
au
0Aaron A R Tobian
1Thomas C Quinn
2Ronald H Gray
3Joseph Monsonego
formatjournal
genrearticle
ristypeJOUR
atitleMale circumcision for prevention of oncogenic HPV infection/Author's reply
jtitleThe Lancet (British edition)
date2011-07-23
risdate2011
volume378
issue9788
spage314
pages314-
issn0140-6736
eissn1474-547X
codenLANCAO
abstractThe quadrivalent HPV vaccine only reduces external genital lesions in men by 60.2% and persistent infection with any HPV genotype by 27.1%.6 Therefore, several interventions might be required to significantly reduce high-risk HPV infection in men and women, and the potential, albeit incomplete, protection afforded by male circumcision cannot be ignored. [...] male circumcision was effective in reducing HPV incidence in female partners, with the best results seen in younger women who had fewer sexual partners.
copLondon
pubElsevier Limited